SAA1 and neoplasm: A proteomic analysis of serum and tissue samples from RCC patients revealed that SAA1 levels were associated with tumor stage and metastasis, which indicates that SAA1 acts as a potential specific biomarker for aggressive clear cell RCC [22–25].